Document Detail

Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis.
MedLine Citation:
PMID:  19654536     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To investigate the long-term effect of oral acyclovir administered during the first 6 months after penetrating keratoplasty (PK) for herpetic eye disease (HED). METHODS: A 5-year follow-up was undertaken for a patient population from a placebo-controlled, randomized trial on acyclovir prophylaxis after keratoplasty. In this former study the effectiveness of oral acyclovir prophylaxis was significant during the first 2 years after keratoplasty. Prospective data such as graft survival, graft clarity, vascularization, infective events, and rejection episodes were obtained from the national keratoplasty follow-up registry. Additional clinical data were derived from the medical charts. RESULTS: For 47 of the original 63 enrolled patients, the 5-year follow-up was completed. Comparing the acyclovir group with the placebo group, we found that with regard to the cumulative clinically evident recurrences, there was a statistically significant lower monthly event rate in the acyclovir group (P = 0.037). There were no statistically significant differences in visual acuity or in the use of oral aciclovir between the two treatment groups. The incidences of graft failure, vascularization, and medication or surgery for glaucoma were too low to analyze differences between the two groups. CONCLUSION: The results of our study suggest that oral acyclovir prescribed during the first 6 months after PK for HED protects against clinically evident HED recurrences during the first 5 years following PK.
Aateke F G Jansen; Wilhelmina J Rijneveld; Lies Remeijer; Henny J M Völker-Dieben; Catharina A Eggink; Annette J M Geerards; Paul G H Mulder; Jeroen van Rooij
Related Documents :
7660076 - Treatment of tuberculous meningitis in turkey.
6255536 - Treatment of pityriasis versicolor with ketoconazole.
18989496 - Intracranial aspergilloma in immunocompetent patients successfully treated with radical...
9216766 - High resolution chest ct in tuberculosis: evolutive patterns and signs of activity.
19793416 - The role of columellar struts to gain and maintain tip projection and rotation: a rando...
3049976 - Heart transplantation in elderly patients.
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Cornea     Volume:  28     ISSN:  1536-4798     ISO Abbreviation:  Cornea     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-25     Completed Date:  2009-10-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8216186     Medline TA:  Cornea     Country:  United States    
Other Details:
Languages:  eng     Pagination:  843-5     Citation Subset:  IM    
Rotterdam Eye Hospital, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acyclovir / administration & dosage*
Administration, Oral
Antiviral Agents / administration & dosage*
Drug Administration Schedule
Follow-Up Studies
Graft Rejection
Graft Survival
Kaplan-Meiers Estimate
Keratitis, Herpetic / drug therapy*,  surgery*
Keratoplasty, Penetrating*
Postoperative Care*
Postoperative Complications
Postoperative Period
Recurrence / prevention & control
Treatment Outcome
Visual Acuity
Reg. No./Substance:
0/Antiviral Agents; 59277-89-3/Acyclovir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparative study of graft rejection in keratoconus patients with and without self-reported atopy.
Next Document:  Allergic conjunctivitis and latent infections.